Medical News: ASCO: Melanoma Survival Benefit Called 'Astounding' - in Meeting Coverage, ASCO from MedPage Today
Check-out the above link for great news for those suffering from skin cancer. Reducing the death rate of metastatic melanoma by 63 percent will be big health news across the nation. Using the drug agent "BRAF inhibitor vemurafenib" (say that fast three times) improved the survival rate of melanoma patients by unprecidented numbers for oncology studies. This was no slacker-study, but a large international trial.
Now, if we could just get folks out of the tanning beds and wearing sunscreen under this unforgiving Mississippi sun . . .
Weekend perusals: Food system policy databases - Policy wonks, students, advocates: If you are looking for data on what countries are doing to promote healthier people and food systems, check out these r...
8 hours ago